Hostile Allergan bid: Cramer hopes Ackman & Valeant whiff By: CNBC.com News April 22, 2014 at 18:16 PM EDT Considering Jim Cramer is a big fan of M&A, why is he so opposed to the Allergan takeover offer? Read More >> Related Stocks: New York Times Company Valeant Pharmaceuticals International, Inc.